About
The Global Pathogens Discovery Laboratory works collaboratively on projects that need microbiology surveillance, identification and discovery. The laboratory was created in response to the need for high quality molecular and culture-based assays to detect, identify, and quantify pathogens, with a particular emphasis on analysis of environmental and animal samples. The founding director, Dr. John Lednicky, has more than 20 years of academic research and industry experience in developing assays to quantify pathogens and identify unknown viruses in environmental, wildlife, and human samples. In response to the current COVID-19 pandemic, we have developed an in-house rtRT-PCR-based assay to detect SARS-CoV-2 in water, air, and human specimens for research purposes. The Laboratory has dedicated BSL2 space and access to BSL3 suites.
Recent News
What is the Nipah virus and why is it more deadly…
See the story below from USA Today featuring an interview with Dr. John Lednicky as he explains the difference between the Nipah virus in Asia and…
UF EPI Supports Testing for New Technology to…
June 24, 2021: UF’s EPI is partnering with Gainesville-based tech company SurfPlasma, Inc. to test a new device’s ability to kill pathogens —…
Dr. Ilaria Capua published in The Lancet: “The…
The current vaccination campaign against SARS-CoV-2 has many challenging aspects, one of which is maintaining the cold chain for the distribution…
